| HIV drug resistance to integrase inhibitors in low-and middle-income countries J Fokam, S Inzaule, V Colizzi, CF Perno, J Kaseya, N Ndembi Nature Medicine 30 (3), 618-619, 2024 | | 2024 |
| First case report of a perinatally HIV-infected infant with HIV resistance to dolutegravir associated with tenofovir/lamivudine/dolutegravir use in mothers K Francois, JD Van Onacker, MR Jordan, I Journel, J Buteaue, E Pierre, ... AIDS 37 (13), 2097-2099, 2023 | 2 | 2023 |
| Need assessment for HIV drug resistance testing and landscape of current and future Technologies in Low-and middle-income countries N Parkin, PR Harrigan, S Inzaule, S Bertagnolio PLOS Global Public Health 3 (10), e0001948, 2023 | 2 | 2023 |
| Recommendations on data sharing in HIV drug resistance research SC Inzaule, MJ Siedner, SJ Little, S Avila-Rios, A Ayitewala, RJ Bosch, ... PLoS medicine 20 (9), e1004293, 2023 | | 2023 |
| Recommendations on data sharing in HIV drug resistance research. S Avila-Rios, A Ayitewala, R Bosch, V Calvez, F Ceccherini-Silberstein, ... PLoS Medicine 20 (9), 2023 | | 2023 |
| Prevalence of pretreatment drug resistance in persons initiating and reinitiating antiretroviral therapy in Sri Lanka: results from a national representative survey J Elwitigala, L Rajapaksa, SC Inzaule, KAM Ariyaratne, S Jayasena, ... Journal of Antimicrobial Chemotherapy 78 (6), 1476-1479, 2023 | | 2023 |
| Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study J Smith, L Bansi-Matharu, V Cambiano, D Dimitrov, A Bershteyn, ... The Lancet HIV 10 (4), e254-e265, 2023 | 22 | 2023 |
| Entangled epidemics: tackling vaccine-preventable diseases in the era of frequent epidemics in Africa V Kouamou, S Inzaule Pan African Medical Journal 46 (1), 2023 | | 2023 |
| Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis AK Ahluwalia, S Inzaule, RC Baggaley, M Vitoria, R Schaefer, ... AIDS 36 (13), 1897-1898, 2022 | 5 | 2022 |
| Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: Multicountry longitudinal cohort analysis SC Inzaule, S Kroeze, CM Kityo, M Siwale, S Akanmu, M Wellington, ... Aids 36 (10), 1437-1447, 2022 | 13 | 2022 |
| Epidemiology of HIV drug resistance in low-and middle-income countries and WHO global strategy to monitor its emergence S Bertagnolio, MR Jordan, A Giron, S Inzaule Current Opinion in HIV and AIDS 17 (4), 229-239, 2022 | 13 | 2022 |
| Weight gain stopping/switch rules for antiretroviral clinical trials V Kouamou, S Inzaule, J Manasa AIDS 36 (7), 1053-1054, 2022 | | 2022 |
| Impact of nucleos (t) ide reverse transcriptase inhibitor resistance on dolutegravir and protease-inhibitor-based regimens in children and adolescents in Kenya L Kingwara, SC Inzaule, L Momanyi, MR Jordan, W Nyanya, N Bowen, ... Aids 36 (4), 611-613, 2022 | 9 | 2022 |
| The prevalence of pre‐treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017–2018 VQ Dat, NTL Anh, K Van Nghia, NT Linh, HHK Thu, TTM Tam, T Ton, ... Journal of the International AIDS Society 25 (2), e25857, 2022 | 3 | 2022 |
| The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey VQ Dat, NTL Anh, K Van Nghia, NT Linh, HHK Thu, TTM Tam, T Ton, ... | | 2022 |
| Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria J Anejo-Okopi, E Okeke, PM Davwar, C Onwuamah, H Onywera, ... African Journal of Laboratory Medicine 11 (1), 1-7, 2022 | | 2022 |
| Dolutegravir drug-resistance monitoring in Africa V Kouamou, S Inzaule, J Manasa The Lancet HIV 8 (11), e664-e666, 2021 | 9 | 2021 |
| Genomic-informed pathogen surveillance in Africa: opportunities and challenges SC Inzaule, SK Tessema, Y Kebede, AEO Ouma, JN Nkengasong The Lancet Infectious Diseases 21 (9), e281-e289, 2021 | 147 | 2021 |
| Hypertension and associated inflammatory markers among HIV-infected patients in Tanzania P Memiah, L Nkinda, M Majigo, Y Opanga, F Humwa, S Inzaule, ... Journal of Interferon & Cytokine Research 41 (8), 291-301, 2021 | 5 | 2021 |
| Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor–containing antiretroviral … S Bertagnolio, L Hermans, MR Jordan, S Avila-Rios, C Iwuji, A Derache, ... The Journal of infectious diseases 224 (3), 377-388, 2021 | 47 | 2021 |
